InfuSystem Holdings (INFU) EBITDA (2010 - 2026)
InfuSystem Holdings (INFU) posted EBITDA of $1.6 million for Q1 2026, down 57.19% on a QoQ basis from $3.7 million in Q4 2025, and up 157.28% year-over-year from $618000.0 in Q1 2025.
InfuSystem Holdings (INFU) EBITDA (2010 - 2026) Analysis & Trends
InfuSystem Holdings' EBITDA history runs 17 years deep, the most recent figure standing at $1.6 million for Q1 2026.
- Quarterly EBITDA rose 157.28% year-over-year to $1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.9 million (up 54.32% YoY) and the FY2025 annual result came in at $11.9 million, up 72.98% from the prior year.
- EBITDA was $1.6 million for Q1 2026 at InfuSystem Holdings, down from $3.7 million in the prior quarter.
- Across five years, EBITDA topped out at $3.8 million in Q3 2025 and bottomed at -$845000.0 in Q1 2024.
- A 5-year average of $1.5 million and a median of $1.2 million in 2023 frame the typical range for EBITDA.
- Annual changes were most pronounced in 2023 — EBITDA soared 502.9% — and 2024, when it sank 689.72%.
- InfuSystem Holdings' EBITDA stood at $1.0 million in 2022, then gained by 21.48% to $1.2 million in 2023, then soared by 109.28% to $2.6 million in 2024, then soared by 41.97% to $3.7 million in 2025, then tumbled by 57.19% to $1.6 million in 2026.
- Business Quant data shows INFU's EBITDA at $1.6 million in Q1 2026, $3.7 million in Q4 2025, and $3.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.83 Bn | 176.54 Bn | 6.27 Bn | 1.35 Bn |
| 2 | Stryker | 128.96 Bn | 126.08 Bn | 3.81 Bn | 936.00 Mn |
| 3 | Medtronic | 108.62 Bn | 99.40 Bn | 6.41 Bn | 1.87 Bn |
| 4 | Boston Scientific | 68.62 Bn | 67.16 Bn | 3.61 Bn | 1.10 Bn |
| 5 | Edwards Lifesciences | 48.35 Bn | 44.67 Bn | 1.29 Bn | 477.60 Mn |
| 6 | Dexcom | 28.45 Bn | 27.33 Bn | 750.30 Mn | 255.30 Mn |
| 7 | GE HealthCare Technologies | 28.18 Bn | 25.90 Bn | 1.98 Bn | 515.00 Mn |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 24.68 Bn | 21.55 Bn | 2.07 Bn | 282.15 Mn |
| 10 | InfuSystem Holdings | 188.97 Mn | 186.87 Mn | 19.68 Mn | 1.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.59 Mn |
| Dec 31, 2025 | 3.71 Mn |
| Sep 30, 2025 | 3.81 Mn |
| Jun 30, 2025 | 3.78 Mn |
| Mar 31, 2025 | 618,000.00 |
| Dec 31, 2024 | 2.62 Mn |
| Sep 30, 2024 | 3.27 Mn |
| Jun 30, 2024 | 1.86 Mn |
| Mar 31, 2024 | -845,000.00 |
| Dec 31, 2023 | 1.25 Mn |
| Sep 30, 2023 | 1.70 Mn |
| Jun 30, 2023 | 1.25 Mn |
| Mar 31, 2023 | -107,000.00 |
| Dec 31, 2022 | 1.03 Mn |
| Sep 30, 2022 | 943,000.00 |
| Jun 30, 2022 | 207,000.00 |
| Mar 31, 2022 | -525,000.00 |
| Dec 31, 2021 | 1.60 Mn |
| Sep 30, 2021 | -351,000.00 |
| Jun 30, 2021 | 696,000.00 |